<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"
					xmlns:content="http://purl.org/rss/1.0/modules/content/"
					xmlns:wfw="http://wellformedweb.org/CommentAPI/"
				  >
<channel>
<title>BUniverse: Videos tagged bionic pancreas </title>
<link>https://www.bu.edu/buniverse/search/?q=&amp;sort=relevance&amp;view=thumbnail&amp;tag=bionic+pancreas</link>
<description><![CDATA[BUniverse: Videos tagged bionic pancreas ]]></description>
<item>
<title>Boston University&acirc;&euro;&trade;s 2014 University Lecture Presented by Edward Damiano</title>
<link>https://www.bu.edu/buniverse/view/?v=2BqDqF1Wb</link>
<guid>https://www.bu.edu/buniverse/view/?v=2BqDqF1Wb</guid>
<pubDate>Tue, 18 Nov 2014 12:00:08 -0500</pubDate>
<description><![CDATA[A Bionic Pancreas for Type 1 Diabetes:  The Long-Awaited Alternative to the Ever-Elusive Cure

Presented by Edward Damiano, Associate Professor of Biomedical Engineering

Edward R. Damiano is an Associate Professor of Biomedical Engineering in the Boston University College of Engineering, where he has taught since 2004.  His expertise and training are in the areas of mechanical and biomedical engineering, applied mechanics, and applied mathematics.

Professor Damiano has gained worldwide attention over the last decade for groundbreaking work in the treatment of Type 1 diabetes. Ever since his 15-year-old son, David, was diagnosed at 11 months of age, Professor Damiano has been committed to the development of a bionic endocrine pancreas â€“ a device that mimics its namesake through a closed-loop, automatic control algorithm that manages blood sugar levels through the delivery of insulin and glucagon.

Starting with a seed grant from the BU Coulter Translational Research Program in 2006, Professor Damiano has gone on to raise more than $14 million to support his research from a variety of sources, including the National Institutes of Health, the National Science Foundation, and the Juvenile Diabetes Research Foundation. He has tirelessly driven the designs of the experimental protocols and the clinical trials necessary to move the technology towards FDA approval and commercial availability. The device has been successfully used in trials by dozens of adults and children, and now includes a special iPhone app that assists patients in monitoring and controlling glucose levels and insulin needs.

The author of dozens of seminal journal articles and seminars exploring endocrinology and biomechanics, Professor Damiano is a graduate of Rensselaer Polytechnic Institute, where he also received his PhD in Applied Mechanics. He received his Masterâ€™s in Mechanical Engineering from Washington University in St. Louis. In addition to his work at BU, he is an Associate Biomedical Engineer in the Division of Medicine at Massachusetts General Hospital.

November 12, 2014]]></description>
</item>
<item>
<title>The Impact of the iLet Bionic Pancreas, Created by a BU Professor | You Are Why</title>
<link>https://www.bu.edu/buniverse/view/?v=1Pifjt2Z8</link>
<guid>https://www.bu.edu/buniverse/view/?v=1Pifjt2Z8</guid>
<pubDate>Mon, 22 Sep 2025 15:04:41 -0400</pubDate>
<description><![CDATA[Rory Mansfield has type 1 diabetes, but these days he can visit a friend’s house. Play soccer. Eat what he wants. Like any other kid. It’s all thanks to the iLet Bionic Pancreas—developed in a Boston University lab by engineering professor Ed Damiano—which automatically delivers just enough insulin to correct the user’s blood sugar.

Rory’s mother, pediatrician Betsey Monaco, says she and her husband, Paul Mansfield, lost a lot of sleep testing, giving injections, and just worrying about Rory and his brother Frankie, who also has type 1. Then, in 2023, Rory got the iLet from Beta Bionics, a company Damiano co-founded.

Monaco talks to Damiano about how the iLet allows Rory to live a more normal life. Damiano began conceptualizing the device in 2000, shortly after his son was diagnosed with type 1 diabetes at age 11 months. He began preclinical testing at BU in 2005. Damiano says he’s delighted that, in the short time the device has been commercially available, it has already found its way into the lives of tens of thousands of families like Monaco’s: “The project has been more rewarding than I ever imagined.”]]></description>
</item>
</channel>
</rss>